As of December 14, 2020, Tenzing Acquisition Corp. was acquired by Reviva Pharmaceuticals, Inc., in a reverse merger transaction. Tenzing Acquisition Corp. does not have significant operations. It intends to acquire, engage in a share exchange, share reconstruction and amalgamation with, purchase all or substantially all of the assets of, enter into contractual arrangements with, or engage in any other similar business combination with one or more businesses or entities primarily operates in India. The company was founded in 2018 and is based in New York, New York.
Research context
Tenzing Acquisition Corp appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Financial Services
- Industry
- Shell Companies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Tenzing Acquisition Corp is currently in a long term downtrend where the price is trading 25.5% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Tenzing Acquisition Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 354.5% to $-348K since the same quarter in the previous year.
Finally, its free cash flow fell by 253.1% to $-272K since the same quarter in the previous year.
Based on the above factors, Tenzing Acquisition Corp gets an overall score of 1/5.